JP2005506335A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506335A5
JP2005506335A5 JP2003532495A JP2003532495A JP2005506335A5 JP 2005506335 A5 JP2005506335 A5 JP 2005506335A5 JP 2003532495 A JP2003532495 A JP 2003532495A JP 2003532495 A JP2003532495 A JP 2003532495A JP 2005506335 A5 JP2005506335 A5 JP 2005506335A5
Authority
JP
Japan
Prior art keywords
compound
condition
group
heteroaryl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003532495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506335A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/031678 external-priority patent/WO2003029247A1/en
Publication of JP2005506335A publication Critical patent/JP2005506335A/ja
Publication of JP2005506335A5 publication Critical patent/JP2005506335A5/ja
Pending legal-status Critical Current

Links

JP2003532495A 2001-10-04 2002-10-04 神経栄養剤としてのn−ヘテロシクリルヒドラジド Pending JP2005506335A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32701901P 2001-10-04 2001-10-04
PCT/US2002/031678 WO2003029247A1 (en) 2001-10-04 2002-10-04 N-heterocyclyl hydrazides as neurotrophic agents

Publications (2)

Publication Number Publication Date
JP2005506335A JP2005506335A (ja) 2005-03-03
JP2005506335A5 true JP2005506335A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23274781

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003532495A Pending JP2005506335A (ja) 2001-10-04 2002-10-04 神経栄養剤としてのn−ヘテロシクリルヒドラジド

Country Status (10)

Country Link
US (1) US7087628B2 (cg-RX-API-DMAC7.html)
EP (1) EP1448553B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005506335A (cg-RX-API-DMAC7.html)
AT (1) ATE294794T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002334836B2 (cg-RX-API-DMAC7.html)
CA (1) CA2462419A1 (cg-RX-API-DMAC7.html)
DE (1) DE60204046T2 (cg-RX-API-DMAC7.html)
ES (1) ES2242096T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04003216A (cg-RX-API-DMAC7.html)
WO (1) WO2003029247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918286B1 (en) * 2006-11-05 2011-12-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thiazolhydrazides for treatment of neurodegenerative diseases
WO2012027548A1 (en) * 2010-08-25 2012-03-01 The Feinstein Institute For Medical Research Compounds and methods for prevention and treatment of alzheimer's and other diseases
EP3515427A4 (en) 2016-09-26 2020-10-14 Qingdao Primedicine Pharmaceutical Co., Ltd N-METHYL D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR USING THEM
PL233208B1 (pl) * 2018-09-17 2019-09-30 Politechnika Wroclawska Iminowe pochodne aldehydów salicylowych i hydrazydu kwasu 4-hydroksybenzoesowego oraz sposób ich wytwarzania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665173A (en) * 1982-03-31 1987-05-12 Klayman Daniel L 2-acetyl- and 2-propionylpyridine selenosemicarbazones
US4694004A (en) * 1984-07-09 1987-09-15 Fujisawa Pharmaceutical Co., Ltd. Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
ES2161594B1 (es) * 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
US6544976B1 (en) 1999-07-09 2003-04-08 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
US6323215B1 (en) 1999-07-09 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
HUP0304058A2 (hu) * 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények

Similar Documents

Publication Publication Date Title
JP5277168B2 (ja) 血小板過剰を治療するbclインヒビター
JP2002520416A5 (cg-RX-API-DMAC7.html)
KR101059379B1 (ko) 아미노사이클로헥실 에테르 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP2003535843A5 (cg-RX-API-DMAC7.html)
CN105412092B (zh) 用于降低眼内压的[3-(1-(1h-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯前药
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
EA023500B1 (ru) Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты
RU2004136853A (ru) (s)-4-амино-5-хлор-2-метокси-n-[1-[1-(2-тетрагидрофурилкарбонил)-4- пиперидини лметил]-4-пиперидинил]бензамид, способ его получения, содержащая его фармацевтическая композиция и промежуточное соединение для его получения
JP2006515613A5 (cg-RX-API-DMAC7.html)
JP2010533131A5 (cg-RX-API-DMAC7.html)
JP2012508251A5 (cg-RX-API-DMAC7.html)
WO2023055702A1 (en) Main protease (m pro) inhibitors and methods using same
JP4722288B2 (ja) 神経学上の傷害および毛髪損失を治療するために使用されるaza−複素環式化合物
JP2005510457A5 (cg-RX-API-DMAC7.html)
JP2006508090A5 (cg-RX-API-DMAC7.html)
JP2002530378A5 (cg-RX-API-DMAC7.html)
HUP0102532A2 (hu) Idegrendszeri betegségek és hajhullás kezelésére szolgáló aza-heterociklusos vegyületek és eljárás az előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
JP2005508292A5 (cg-RX-API-DMAC7.html)
SK18292000A3 (sk) Močoviny a karbamáty n-heterocyklických karboxylových kyselín a izosterov karboxylových kyselín, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
JP2005517634A5 (cg-RX-API-DMAC7.html)
FR2593499A1 (fr) Aminoalcools, leur procede de preparation et leurs applications, notamment en therapeutique
WO2005097203A2 (en) Serum protein conjugates of ion channel modulating compounds and uses thereof
AU2014252281A1 (en) Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
JP2002536442A5 (cg-RX-API-DMAC7.html)
JP2006520396A5 (cg-RX-API-DMAC7.html)